tiprankstipranks
Trending News
More News >
Sanofi (SNY)
NASDAQ:SNY
US Market

Sanofi (SNY) Ratios

Compare
1,980 Followers

Sanofi Ratios

SNY's free cash flow for Q1 2025 was €0.73. For the 2025 fiscal year, SNY's free cash flow was decreased by € and operating cash flow was €0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.46 1.27 1.42 1.44 1.75
Quick Ratio
1.14 0.87 1.05 1.03 1.32
Cash Ratio
0.26 0.36 0.53 0.47 0.72
Solvency Ratio
0.17 0.18 0.23 0.18 0.30
Operating Cash Flow Ratio
0.31 0.42 0.44 0.49 0.39
Short-Term Operating Cash Flow Coverage
2.16 4.42 2.36 3.05 2.48
Net Current Asset Value
€ -12.35B€ -21.46B€ -17.54B€ -20.65B€ -17.46B
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.15 0.17 0.19 0.21
Debt-to-Equity Ratio
0.23 0.25 0.28 0.33 0.38
Debt-to-Capital Ratio
0.19 0.20 0.22 0.25 0.27
Long-Term Debt-to-Capital Ratio
0.13 0.16 0.17 0.20 0.24
Financial Leverage Ratio
1.71 1.71 1.69 1.75 1.81
Debt Service Coverage Ratio
1.98 3.04 2.45 2.55 4.63
Interest Coverage Ratio
9.68 7.20 36.43 22.08 20.72
Debt to Market Cap
0.14 0.15 0.34 0.37 0.46
Interest Debt Per Share
14.91 15.59 17.31 18.19 19.20
Net Debt to EBITDA
0.95 0.81 0.60 1.09 0.56
Profitability Margins
Gross Profit Margin
70.18%69.07%69.83%68.72%67.47%
EBIT Margin
16.82%17.86%24.32%20.83%38.11%
EBITDA Margin
24.91%26.06%30.98%28.82%46.87%
Operating Profit Margin
16.38%17.11%37.00%20.74%21.63%
Pretax Profit Margin
15.26%15.54%23.11%19.91%36.94%
Net Profit Margin
12.55%11.73%18.44%15.89%32.90%
Continuous Operations Profit Margin
12.54%11.81%18.69%16.03%33.00%
Net Income Per EBT
82.27%75.49%79.80%79.80%89.06%
EBT Per EBIT
93.19%90.83%62.46%95.96%170.80%
Return on Assets (ROA)
4.19%4.27%6.61%5.18%10.75%
Return on Equity (ROE)
7.17%7.29%11.19%9.06%19.48%
Return on Capital Employed (ROCE)
7.00%7.70%16.34%8.21%8.49%
Return on Invested Capital (ROIC)
5.51%5.84%12.67%6.35%7.15%
Return on Tangible Assets
8.33%10.24%15.17%12.26%23.78%
Earnings Yield
4.77%4.77%14.78%11.28%24.67%
Efficiency Ratios
Receivables Turnover
4.17 4.17 4.22 4.00 3.75
Payables Turnover
1.75 1.94 2.01 1.98 2.30
Inventory Turnover
1.40 1.47 1.53 1.41 1.46
Fixed Asset Turnover
3.82 3.90 3.88 3.27 3.54
Asset Turnover
0.33 0.36 0.36 0.33 0.33
Working Capital Turnover Ratio
4.45 5.57 4.70 3.30 3.29
Cash Conversion Cycle
139.57 147.48 143.65 166.69 189.00
Days of Sales Outstanding
87.60 87.54 86.41 91.19 97.22
Days of Inventory Outstanding
260.68 247.83 238.85 259.57 250.76
Days of Payables Outstanding
208.72 187.88 181.62 184.06 158.98
Operating Cycle
348.29 335.37 325.27 350.75 347.97
Cash Flow Ratios
Operating Cash Flow Per Share
7.26 8.20 8.41 8.40 5.94
Free Cash Flow Per Share
4.70 5.87 6.65 6.77 4.26
CapEx Per Share
2.55 2.42 1.76 1.63 1.69
Free Cash Flow to Operating Cash Flow
0.65 0.72 0.79 0.81 0.72
Dividend Paid and CapEx Coverage Ratio
1.15 1.37 1.65 1.74 1.23
Capital Expenditure Coverage Ratio
2.84 3.39 4.78 5.15 3.52
Operating Cash Flow Coverage Ratio
0.51 0.56 0.50 0.47 0.31
Operating Cash Flow to Sales Ratio
0.21 0.22 0.23 0.27 0.20
Free Cash Flow Yield
10.10%12.98%14.70%15.37%10.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.97 20.97 6.76 8.87 4.05
Price-to-Sales (P/S) Ratio
2.63 2.46 1.25 1.41 1.33
Price-to-Book (P/B) Ratio
1.50 1.53 0.76 0.80 0.79
Price-to-Free Cash Flow (P/FCF) Ratio
19.80 15.40 6.80 6.51 9.34
Price-to-Operating Cash Flow Ratio
12.84 11.04 5.38 5.24 6.69
Price-to-Earnings Growth (PEG) Ratio
6.95 -0.59 0.20 -0.18 0.01
Price-to-Fair Value
1.50 1.53 0.76 0.80 0.79
Enterprise Value Multiple
11.51 10.25 4.63 5.98 3.40
EV to EBITDA
6.23 5.53 4.63 5.98 3.40
EV to Sales
1.55 1.44 1.43 1.72 1.59
EV to Free Cash Flow
11.68 9.02 7.82 7.96 11.17
EV to Operating Cash Flow
7.57 6.47 6.18 6.41 8.00
Tangible Book Value Per Share
9.46 0.50 2.89 -0.34 0.44
Shareholders’ Equity Per Share
61.94 59.15 59.74 54.84 50.34
Tax and Other Ratios
Effective Tax Rate
0.18 0.22 0.19 0.20 0.13
Revenue Per Share
35.39 36.78 36.26 31.28 29.81
Net Income Per Share
4.44 4.31 6.69 4.97 9.81
Tax Burden
0.82 0.75 0.80 0.80 0.89
Interest Burden
0.91 0.87 0.95 0.96 0.97
Research & Development to Revenue
0.17 0.15 0.15 0.15 0.15
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 <0.01 <0.01 <0.01
Income Quality
1.65 1.90 1.26 1.69 0.60
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis